WELCOME REMARKS
Steven J. Corwin, MD
President and Chief Executive Officer
NewYork-Presbyterian
and
Katrina A. Armstrong, MD
Dean of the Faculties of Health Sciences
and the Vagelos College of Physicians and Surgeons
Executive Vice President, Health and Biomedical Sciences
Columbia University
DR. JOHN A. CHABOT TRIBUTE VIDEO
THE SEYMOUR MILSTEIN DISTINGUISHED SERVICE AWARD PRESENTATION
Philip L. Milstein
AWARD ACCEPTANCE
John A. Chabot, MD
David V. Habif Professor of Surgery
Columbia University Vagelos College of Physicians and Surgeons
Chief, Division of Hepato-Pancreato-Biliary Surgery
Founder and Co-Director, Pancreas Center
NewYork-Presbyterian/Columbia University Irving Medical Center
DINNER SERVICE
THE SEYMOUR MILSTEIN DISTINGUISHED SERVICE AWARD REMARKS
Steven J. Corwin, MD
DR. ROBIN S. GOLAND TRIBUTE VIDEO
THE SEYMOUR MILSTEIN DISTINGUISHED SERVICE AWARD PRESENTATION
Philip L. Milstein
AWARD ACCEPTANCE
Robin S. Goland, MD
Founder and Co-Director, Naomi Berrie Diabetes Center
J. Merrill Eastman Professor of Clinical Diabetes (in Medicine and Pediatrics)
Columbia University Vagelos College of Physicians and Surgeons
Attending Physician
NewYork-Presbyterian/Columbia University Irving Medical Center
CLOSING REMARKS
Katrina A. Armstrong, MD
View the John A. Chabot, MD Tribute Video
View the Robin S. Goland, MD Tribute Video
ABOUT THE AWARDEES
John A. Chabot, MD
David V. Habif Professor of Surgery
Columbia University Vagelos College of Physicians and Surgeons
Chief, Division of Hepato-Pancreato-Biliary Surgery
Founder and Co-Director, Pancreas Center
NewYork-Presbyterian/Columbia University Irving Medical Center
John A. Chabot, MD, is a beloved and revered pancreatic cancer surgeon, and Founder of the Pancreas Center at NewYork-Presbyterian/Columbia University Irving Medical Center.
Established in 2006, the Pancreas Center is one of the largest and most effective clinical cancer programs in the world, as well as a transformative research center where scientific discovery leads to trials of new pancreatic cancer therapies.
Under Dr. Chabot’s leadership, the Pancreas Center has grown from an informal collaboration to a comprehensive faculty of clinical specialists and scientific and translational researchers. This team now includes three full-time medical oncologists and numerous specialists who support pancreatic patient needs, as well as 13 different full- and part-time laboratories dedicated to pancreas cancer research—more than at any other academic medical center.
Dr. Chabot is the David V. Habif Professor of Surgery at Columbia University Vagelos College of Physicians and Surgeons, Chief of Hepato-Pancreato-Biliary (HPB) Surgery at NewYork-Presbyterian/Columbia University Irving Medical Center, and served as Vice President of ColumbiaDoctors for many years. He is known for the close rapport he builds with his patients. A highly regarded surgeon, he has performed more than 2,500 Whipple procedures—a complex operation to remove pancreatic tumors—and participated in many surgical advances that have steadily improved pancreatic cancer outcomes.
Dr. Chabot arrived at NewYork-Presbyterian/Columbia University Irving Medical Center in 1983 as an intern. From intern, resident, and fellow to professor, mentor, and director of the Pancreas Center, he has spent his entire career at NewYork-Presbyterian/Columbia University Irving Medical Center, building an intimate understanding of the culture and practice of medicine and surgery. He sits on the scientific advisory board of Let's Win Pancreatic Cancer and remains singularly committed to the goal of preventing, treating, and curing pancreatic cancer.
Robin S. Goland, MD
Founder and Co-Director, Naomi Berrie Diabetes Center
J. Merrill Eastman Professor of Clinical Diabetes (in Medicine and Pediatrics)
Columbia University Vagelos College of Physicians and Surgeons
Attending Physician
NewYork-Presbyterian/Columbia University Irving Medical Center
Nearly three decades ago, Robin S. Goland, MD, the J. Merrill Eastman Professor of Clinical Diabetes at Columbia University Vagelos College of Physicians and Surgeons and Attending Physician at NewYork-Presbyterian/Columbia University Irving Medical Center, began one of the nation's most successful efforts to advance patient care, research, and education in the field of diabetes.
The Naomi Berrie Diabetes Center at Columbia University Irving Medical Center in New York City, which opened in October 1998 under the direction of Dr. Goland and her Co-director, Dr. Rudolph Leibel, combines premier family-centered patient care and education with world-class diabetes research programs. Today the Naomi Berrie Diabetes Center is co-directed by Dr. Goland and Dr. Anthony Ferrante, and more than 1,200 patients with diabetes are seen monthly. The Naomi Berrie Diabetes Center patient population, now numbering more than 10,000 people, is extraordinarily diverse, including patients of all ages, ethnic backgrounds, and socioeconomic status.
The mission of the Naomi Berrie Diabetes Center is to provide "the care until the cure." The clinical space is directly adjacent to research laboratories working on prevention, treatment, and ultimately, the cure of diabetes. Because of close collaboration between clinicians and investigators at the Naomi Berrie Diabetes Center, advances made at the research bench are made available to the patients as rapidly as possible. The Naomi Berrie Diabetes Center has one of the largest pediatric and adult type 1 diabetes clinical practices in the country. It is a leader in clinical diabetes research in children and adults. A major focus of Dr. Goland's work is on translational research and clinical trials, in adult and pediatric patients with type 1 diabetes and type 2 diabetes. She is a leader of many NIH and other multicenter clinical diabetes trials as well as on collaborative investigator-initiated translational research studies aimed, ultimately, at curing diabetes.
Dr. Goland received her BA from Harvard University and her MD from Columbia University Vagelos College of Physicians and Surgeons. She was a medical resident and Chief Resident at NewYork-Presbyterian/Columbia University Irving Medical Center and did her Endocrinology Postdoctoral training at Columbia University. She has been on the medical school faculty at Columbia University Vagelos College of Physicians and Surgeons since 1987. Dr. Goland is a member of the Board of Trustees of the Riverview School in East Sandwich, Massachusetts and is a past medical advisory board member of the Juvenile Diabetes Research Foundation.
